Methods Primer: Extrapolation beyond the end of trials to estimate long term survival and cost-effectiveness.
16 Mar, 2022 | 09:44h | UTC
Commentary on Twitter
New: Useful information here from @NRLatimer @DrAmandaAdler: “Extrapolating Beyond the End of Trials to Estimate Long-term Survival and Cost-effectiveness” ➡️ https://t.co/ULgDfhg2cX#NewArticle #BMJMedicine #MedTwitter pic.twitter.com/Y4RDLxVHSv
— BMJMedicine (@BMJMedicine) March 15, 2022